methyltestosterone

ATC code
G03EK01
Therapeutic class
Sex hormones and modulators of the genital system · Androgen combined with estrogens for menopausal symptoms
Forms
Oral tablet with esterified estrogens 0.625 mg and methyltestosterone 1.25 mg, Oral tablet with esterified estrogens 1.25 mg and methyltestosterone 2.5 mg
Brand names
Esterified Estrogens and Methyltestosterone (US)
Overall confidence
high

Regulatory sources consulted

Approved indications

Contraindications

Absolute

  • Undiagnosed genital bleeding, known or suspected breast cancer, or estrogen-dependent neoplasia.
  • Current or prior deep-vein thrombosis, pulmonary embolism, arterial thromboembolic disease, or thrombophilia.
  • Liver disease, pregnancy, or hypersensitivity to components.

Clinical warnings

Drug interactions

Adverse events

Common (≥1%)

Headache · Breast pain · Nausea · Acne or hirsutism · Voice changes · Uterine bleeding

Rare but serious

Thrombosis or embolism · Peliosis hepatis or liver tumor · Irreversible virilization

Pregnancy and lactation

Contraindicated during pregnancy and in breastfeeding mothers because of the possibility of masculinization of a female fetus or breastfed infant.

Recent literature (PubMed)